PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 57 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q3 2018. The put-call ratio across all filers is 1.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $4,695,000 | -13.3% | 5,556,778 | 0.0% | 0.39% | +2.4% |
Q2 2019 | $5,418,000 | -22.6% | 5,556,778 | 0.0% | 0.38% | +4.4% |
Q1 2019 | $7,002,000 | -61.1% | 5,556,778 | 0.0% | 0.36% | -49.0% |
Q4 2018 | $18,004,000 | +34.4% | 5,556,778 | 0.0% | 0.71% | +23.5% |
Q3 2018 | $13,392,000 | -13.6% | 5,556,778 | 0.0% | 0.58% | -20.4% |
Q2 2018 | $15,503,000 | -41.3% | 5,556,778 | 0.0% | 0.73% | -38.2% |
Q1 2018 | $26,395,000 | -18.5% | 5,556,778 | 0.0% | 1.17% | -12.5% |
Q4 2017 | $32,396,000 | +333.7% | 5,556,778 | +56.2% | 1.34% | +412.2% |
Q3 2017 | $7,469,000 | -55.1% | 3,556,778 | 0.0% | 0.26% | -56.8% |
Q2 2017 | $16,646,000 | -40.2% | 3,556,778 | 0.0% | 0.61% | -37.3% |
Q1 2017 | $27,814,000 | -36.2% | 3,556,778 | 0.0% | 0.97% | -44.2% |
Q4 2016 | $43,606,000 | -21.4% | 3,556,778 | 0.0% | 1.73% | -30.3% |
Q3 2016 | $55,450,000 | +47.7% | 3,556,778 | +14.9% | 2.49% | +27.7% |
Q2 2016 | $37,545,000 | +25.8% | 3,095,240 | 0.0% | 1.95% | -1.6% |
Q1 2016 | $29,838,000 | – | 3,095,240 | – | 1.98% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management III, LLC | 848,610 | $2,749,000 | 2.00% |
GREAT POINT PARTNERS LLC | 3,045,423 | $9,867,000 | 1.25% |
NEA Management Company, LLC | 5,556,778 | $18,004,000 | 0.71% |
VHCP Management II, LLC | 501,390 | $1,625,000 | 0.70% |
SECTORAL ASSET MANAGEMENT INC | 1,581,728 | $5,125,000 | 0.70% |
HARBOURVEST PARTNERS LLC | 440,627 | $1,428,000 | 0.68% |
EAM Investors, LLC | 596,871 | $1,934,000 | 0.52% |
EAM Global Investors LLC | 252,778 | $819,000 | 0.45% |
Avoro Capital Advisors LLC | 1,300,000 | $4,212,000 | 0.25% |
Ghost Tree Capital, LLC | 190,000 | $616,000 | 0.22% |